Not Tagged
merck
['bladder', 'serono']
data analysis does not end with the publication of primary results of a clinical study. evaluating long-term results can help us understand how to further optimize treatment for patients with #bladdercancer. #esmo22
Official Twitter for US Oncology business of EMD Serono a business of Merck KGaA Darmstadt, Germany. 
Intended for U.S. audience
CG: ??https://t.co/DN8q8OvEDb